0000950170-24-025915.txt : 20240305
0000950170-24-025915.hdr.sgml : 20240305
20240305161211
ACCESSION NUMBER: 0000950170-24-025915
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240302
FILED AS OF DATE: 20240305
DATE AS OF CHANGE: 20240305
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lamothe Jeffrey G.
CENTRAL INDEX KEY: 0001679967
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37746
FILM NUMBER: 24720478
MAIL ADDRESS:
STREET 1: 2401 4TH AVENUE
STREET 2: SUITE 1050
CITY: SEATTLE
STATE: WA
ZIP: 98121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aptevo Therapeutics Inc.
CENTRAL INDEX KEY: 0001671584
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 811567056
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2401 4TH AVE.
STREET 2: SUITE 1050
CITY: SEATTLE
STATE: WA
ZIP: 98121
BUSINESS PHONE: 206-838-0500
MAIL ADDRESS:
STREET 1: 2401 4TH AVE.
STREET 2: SUITE 1050
CITY: SEATTLE
STATE: WA
ZIP: 98121
4
1
ownership.xml
4
X0508
4
2024-03-02
0001671584
Aptevo Therapeutics Inc.
APVO
0001679967
Lamothe Jeffrey G.
2401 4TH AVENUE
SUITE 1050
SEATTLE
WA
98121
false
true
false
false
EVP, COO
false
Common Stock
2024-03-02
4
M
false
5500
A
33837
D
Common Stock
2024-03-03
4
M
false
3667
A
37504
D
Restricted Stock Unit
2024-03-02
4
M
false
5500
0
D
Common Stock
5500
11000
D
Restricted Stock Unit
2024-03-03
4
M
false
3667
0
D
Common Stock
3667
3667
D
Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
On March 3, 2023, the reporting person was granted 16,500 RSUs, vesting in three approximately equal annual installments beginning on March 2, 2024.
On June 7, 2022, the reporting person was granted 11,000 RSUs, vesting in three approximately equal annual installments beginning on March 3, 2023.
/s/ SoYoung Kwon, Attorney-in-Fact
2024-03-05